Table 1. Inhibitors of VWF-mediated platelet adhesion.

A detailed description of each of these inhibitors is given in Table S1 (please see http://stroke.ahajournals.org).

Compound	Description
82D6A3	Monoclonal antibody against VWF A3 domain that inhibits binding of VWF to collagen
6B4 h6B4	Fab-fragment of a monoclonal antibody against platelet GPIbα that inhibits binding of VWF to GPIb
AJvW2 AJW200	Monoclonal antibody against VWF A1 domainα that inhibits binding of VWF to GPIbα
GPG-290	Chimeric recombinant protein containing gain-of-function GPIbα fragment that binds to A1 domain thereby inhibiting binding of VWF to GPIbα
ARC1779	Aptamer against VWF A1 domain that inhibits binding of VWF to GPIbα
ALX-0081 ALX-0681	Nanobody® against VWF A1 domain that inhibits binding of VWF to GPIbα
rADAMTS13	Recombinant protein that cleaves VWF multimers by cleaving the Y1605-M1606 bond in the VWF A2 domain